PPTA Presents at ESID 2012

PPTA presents at the 15th Biennial Meeting of the European Society of Immunodeficiencies (ESID 2012) held in collaboration with the International Patient Organisation of Patients with Immunodeficiency (IPOPI) and the International Nurses Group for Immune Deficiency (INGID).

October 3-6
Florence, Italy

Presentations:

"A Decision Analysis Model for Estimating Latent Therapeutic Demand for Immunoglobulin Therapy in Primary Immune Deficiencies" - Albert Farrugia, Vice President, PPTA Global Access

"The Production of Safe Plasma Derivatives from Vein to Vein" - Jan M. Bult, PPTA President and CEO

Created on June 25 2012.

Media and Information

PPTA News

Public Review until April 21: Proposed Confirmation of Two IQPP Standards +
The following proposed actions are hereby opened for public review:
- Confirmation (continued implementation) of Version 3.0 of the IQPP Cross Donation Management Standard
- Confirmation (continued implementation) of Version 1.0 of the IQPP Donor Fluid Administration Standard
Read More
PPTA encourages EDQM to take a patient-centric approach in the implementation of its Plasma Supply Management Recommendations +

The European Commission and the European Directorate for the Quality of Medicines (EDQM) recently published recommendations on plasma supply management in Europe. The recommendations were drafted by a working group of transfusion specialists representing national blood services (also called the TS093 working group). PPTA thanks the EDQM and the European Commission for addressing this important issue but is concerned that the recommendations do not go far enough towards ensuring the collection of sufficient plasma to meet the growing clinical need for plasma-derived medicinal products (PDMPs).
Read More
New Coronavirus (SARS-CoV-2) and Plasma Protein Therapies (updated February 17, 2020) +

Recent international reports have highlighted the emergence of a new coronavirus in Wuhan, Hubei Province, China (1). The 2019 Novel Coronavirus (2019-noCoV), now called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first identified by Chinese authorities in December 2019 and since then has been associated with pneumonia in over 70,000 persons in China and more than 1,700 deaths (1-3). *
Read More

› ‹

The Source, the international magazine of the plasma protein therapeutics industry, is published quarterly.

Learn more about the need for plasma donors, plasma donation, and how you can save and improve lives. Find a Donation Center.

"How Is Your Day?" is an initiative to raise awareness of the unique nature of plasma protein therapies and the value they provide to patients. It aims to inform and educate decision makers and the general public worldwide.

Get involved and follow "How Is Your Day?" on social media @HIYDglobal

PPTA Presents at ESID 2012

Media and Information

Advocacy